Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
TurtleWax Shell partnership, Move Clean, is a trial in selective markets . It will be some time, possibly over a year, before the results of that trial will be known. The Target trial took nearly 2yrs and eventually ended in March this year.
Covid vaccine is being rolled out so the question is whether it's too little too late.
"Move Clean solutions are piloting in select markets in the US and will be available through key transportation partners, including participating Shell gas stations in the coming months. "
https://www.prnewswire.com/news-releases/shell-lubricants-us-and-turtle-wax-inc-announce-collaboration-with-move-clean-to-launch-total-vehicle-hygiene-services-for-the-automotive-industry-301172004.html
Well that can add to the Solvay Blockbuster quote..2021 License revenues which are 100% profit are going to be very interesting
Thanks 1GW_,
"Can we say game-changer?" - like it!!
Big in the US, big in the US, big in the USA...
"Turtle Wax Teams Up with Byotrol24™ to Introduce Revolutionary Cleaner and Disinfectant Safe for Automotive Interiors"
https://finance.yahoo.com/news/turtle-wax-teams-byotrol24-introduce-130200414.html
WALMART.COM
Turtle Wax | Multi-Purpose Cleaner & Disinfectant with Byotrol® | Car Interior Surface Sanitizer
Shop Now
https://www.facebook.com/turtlewax/
This mis-information from the influential WHICH "consummer watchdog" needs to be addressed immediately by Byotrol's public relations! Not being based on alcohol is a definite plus for the company's products.
From the DT.
"Hand sanitiser being sold online could leave users at risk of covid, a Which? investigation has found.
Tests carried but by the consumer watchdog found a range of products made misleading claims about alcohol content and risk leaving consumers unprotected against coronavirus because they do not contain recommended levels.
The consumer champion found that the worst offending hand sanitiser had an alcohol content of just 10 per cent, a fraction of the 75 per cent claimed - leaving people using it particularly exposed to bacteria and viruses.
For hand sanitiser to be effective at killing the COVID-19 virus, it should have 60 to 90 per cent alcohol content. In Which?'s latest research scientists put a range of 18 products available at high street retailers, supermarkets and online marketplaces to the test.
Three hand sanitisers bought from online marketplaces eBay and Etsy did not contain the percentage of alcohol that was claimed on either the product listing page or the packaging, and fell well short of the recommended levels for killing off viruses.
Klenzy Hand Sanitizing Gel, which was available for sale on eBay, claimed to have 75 per cent alcohol content, but Which? tests revealed people who had bought this product had been duped, as it contained just 10 per cent.
The VaidaMakeup Hand Sanitiser Gel (33% alcohol content), on Etsy, and Hansan Antibacterial Hand Sanitiser (35%), on eBay, were also misleading. Both contained around half of the 70 per cent alcohol levels that were claimed.
After Which? contacted eBay it said it had removed both the product listings that the consumer champion had flagged and that the sellers would no longer be permitted to sell hand sanitiser on the site.
The seller on Etsy told Which? that it had removed the listing and contacted all customers to warn them of the lower alcohol content in the sanitiser and to offer a full refund.
Which? has shared its findings with the Office for Product Safety and Standards (OPSS) for further investigation.
Natalie Hitchins, Which? head of home products and services, said: "It's extremely concerning that hand sanitisers readily available on online marketplaces eBay and Etsy make misleading claims about alcohol content and could leave consumers unwittingly exposed to the COVID-19 virus."
Which? approached the sellers of the Hansan and Klenzy products for comment and did not receive a response.
The seller for the VaidaMakeup hand sanitiser gel said it had removed the listing and contacted all customers to warn them of the lower alcohol content in the sanitiser and to offer a full refund."
incidentally Boots has c2,500 stores in the UK so to get products in every one is a great achievement
The comment “competitors with less effective technologies” is an odd one. Byotrol is a blend of widely available commodity biocides which in isolation are far more effective. Byotrol have shared their IP with the competition as an attempt to partner or licence with no joy, all being able to benchmark the “effectiveness”. Kimberley Clark have their own range, Tesco likewise and several others have tried and moved on: Rentokil, ISS, NHS, M&S, Carnival/P&O.
Most likely the price is lower on the recent news of vaccine development. Shares that have done well during the pandemic, such as this one, have dropped recently (equally the hardest hit companies such as those in travel have seen their shares lift from very low prices) but I don't think this detracts from long term demand for Byotrol products. As Byotrol have stated, competitors with less effective chemistries are withdrawing from Byotrol's market in the UK and Europe as new regulations take hold. The acquisition of Medimark (latest product "Airgene" looks very interesting) also adds to the many opportunities for growth.
Why is BYOT so weak at moment? As a private investor it is difficult to get info apart from company statements. My avge cost is 4p and thinking of topping up. If I knew more I would grade it a Buy.
Will you be expanding in Boots?
Yes. Our alcohol-free hand, anti-viral sanitisers are now being distributed into approximately 2500 Boots stores in the UK
• PR to support Invirtu alcohol-free hand sanitisers
We avoid generic PR spend unless we can see genuine financial payback, as this just reduces profits. We recognise that generic PR may help boost the share price in the short term but Will you be expanding into alcohol-free hand sanitisers in Japan?
Not at present as the individual ingredients in our Invirtu formulation are not all approved by Japanese regulators. Japanese rules allow for very few biocidal chemicals to be used on skin, so the potential for innovation is currently limited. We are hopeful this will change as the world looks for new approaches to personal hygiene.
What is your current thinking on commercialising the seaweed technology?
This is a very exciting area for us in a broad number of potential markets and products. Our main work at present is on fully understanding the mode of action behind the excellent results we have been achieving, particularly against viruses. With that work completed it is likely we will be developing products for our own core infection control markets, plus seeking alliances elsewhere.
What are your current activities in China?
China has been low focus for us in the past year, hindered by lockdown and by the international supply chain situation. We will be looking at Asia again as travel restrictions ease next calendar year.
Other
What is the company’s future PR strategy?
Our main focus this year so far has been on supplying customers speedily with existing products. This has kept us at full capacity, even with some new hires into the Group.
We have made some investments in Financial PR, to keep investors better informed on progress and we plan to continue this.
We are also now making – for us – sizeable investments in marketing and marketing strategy, including:
• Professional market research to help with finalising strategy in our new market environment
• Product proposition development (technologies and claims, based on market and customer insight).
our experience is that this is generally temporary and actually does very little to bring in new sales and long-term customer relationships.
Byotrol plc
AGM for year ended 31 March 2020
Q&A, 14 November 2020
Financials
When will you be putting out guidance for FY 2022?
Byotrol is trading well and we expect that to continue next year. However, as the economy and our markets remain volatile and somewhat difficult to predict, we would not expect our broker finnCap to release forecasts for FY 2022 until there is greater clarity on the likely out-turn.
Do you now intend to pay a dividend and if so when?
The share capital reconstruction approved by shareholders (but still subject to Court approval) will enable the Company to pay a dividend from retained earnings. However, in the near term, the Board consider that there will be opportunities for the Group to invest for future growth as opposed to paying a dividend. However, the Board will keep this policy regularly under review.
Why did you decide to not pursue a share consolidation?
Following the announcement of the potential share consolidation, the Board consulted widely with both institutional and private shareholders albeit that, with more than 500 shareholders, it was not possible to consult with all. The consensus of opinion was that the share consolidation was not favoured at present.
Sales and Business Development
In Solvay’s recent results call, the CEO commented on how “FMCG companies and big brands” were accelerating qualification and the launch. What is Byotrol’s understanding of how Actizone will be sold to consumers? Are we likely to see well-known brands launching “Actizone” products?
Actizone is being marketed globally by Solvay’s Novecare sales force, as an ingredient, a mix of ingredients and as a finished formulation. We do expect Actizone to appear as a brand on some products, but we are not party to the specific commercial discussions that Solvay is having.
What sort of revenue streams can we expect over the coming years from the Solvay deal
We are still benefitting in cash terms from minimum guaranteed revenue from the original IP Agreement, though this was recognised as revenue in FY 2019. We expect this to be supplemented by ‘royalty/commission’ income in FY 2022, although the magnitude is at present completely dependent on how successful Solvay is with its sales and marketing efforts. We are encouraged by progress so far (as evidenced by recent Solvay public statements) but we have no visibility on numbers.
In Byotrol’s recent InvestorMeetCompany presentation, David Traynor said of Solvay’s Actizone: “They gave us usage rights. Anything they develop in this sphere we can brand Byotrol and sell it in our own right.” How and when does Byotrol see these usage rights being exercised?
We are already selling Actizone under our brand (Byotrol 4 in 1) in our Professional business. Actizone is also the technology in our B2C (including pet) long lasting anti-microbial surface products.
Will you be expanding in Boots?
Yes. Our alcohol-free hand, anti-viral sanitisers are now being distr
Of 250K trades going through secretly.......eg: delayed & printed 2 hrs later......I think this will start moving up nicely over the next few weeks.
Byotrol has an impressive list of collaborators now, including Solvay, Shell, Boots, SC Johnson etc.....
hTtps://www.prnewswire.com/news-releases/shell-lubricants-us-and-turtle-wax-inc-announce-collaboration-with-move-clean-to-launch-total-vehicle-hygiene-services-for-the-automotive-industry-301172004.html
""Shell Lubricants US and Turtle Wax, Inc. Announce Collaboration with Move Clean to launch total vehicle hygiene services for the Automotive Industry"
"Move Clean's initial solutions are anchored by Turtle Wax, Inc.'s proprietary disinfecting solution called Defend-X®, that features Byotrol® Technology and is an EPA-registered surface sanitizer that kills over 99.9% of germs, including cold and flu viruses, 2009-H1N1 Influenza A virus, Respiratory Syncytial virus, Coronavirus, Rotavirus and Norovirus. When used as intended, it keeps surfaces sanitized for a full 24 hours with only one application. Defend-X is categorized in the lowest toxicity level (Level IV). Defend-X cleans worry-free, meaning it is non-staining and non-corrosive; there are no harsh chemicals and it does not contain bleach or alcohol."
I liked from today's RNS:
"Demand for IP licensing remains robust, with the team exploring multiple new opportunities both in the UK and internationally."
Also comforting that net cash remains strong, that trading remains in line and that "competitors with weaker performance chemistries continuing to withdraw from our market".
I assume an update from Finncap will show unchanged forecasts for the moment, but there's plenty going on.
Byotrol plc (AIM: BYOT), the specialist infection prevention and control company, makes the following statement ahead of the Company's AGM later today.
The Directors are pleased to report that trading remains at healthy levels, across all business units and product sales. Demand for IP licensing remains robust, with the team exploring multiple new opportunities both in the UK and internationally.
The Group's net cash position remains strong, enabling us to maintain stock levels to fulfil customer demand or where appropriate re-invest for the growth of the business.
We expect results for the year to 31 March 2021 to meet current market expectations, notwithstanding the recent news on the development of potential vaccines against Covid-19. This is supported by industry trends clearly in evidence before (and now magnified by) Covid-19, all of which continue to favour Byotrol's long-term positioning, notably:
• businesses and consumers taking increasingly proactive responsibility for protecting individuals against infection risk from viruses and bacteria, so increasing global demand; and
• competitors with weaker performance chemistries continuing to withdraw from our market in the UK and Europe as new regulations take hold, so reducing the supply of competing products and so multiplying opportunities for Byotrol's future growth.
The Directors remain highly confident in Byotrol's longer term outlook.
https://www.investegate.co.uk/article.aspx?id=202011130700061961F
See Boots are now selling Immunity and Protection Bundles with Byotrol products.
https://www.boots.com/search/Antiviral+foam
Has 1gw just waken up and smell the coffee? Or more likely been Hacked!!
Very Nice update on Byotrol24 home page “EPA has approved the following statement release for Byotrol24”
Great post from 1gw elsewhere - for the CEO of Solvay to say that Actizone is a "blockbuster" product is quite a coup.
Here's the post:
"Transcipt of Solvay earnings call is now up. Search it for "Actizone" to see both substantive mentions. This is the second one (note: "quantification" should read "qualification" I think):
"These formulations for home and personal care for agro feed and somewhat coating and home and personal care, we are so excited that we have accelerated our innovation with Actizone. And that's the blockbuster we are launching. Kills 99.9% germs last 24 hours. It's something the FMCG companies and big brands you know are as we speak accelerating quantification and the launch. So we're very excited with our position and the quality of this business."
Https://www.solvay.com/sites/g/files/srpend221/files/2020-11/Call%20transcript.pdf
All coming together again across pond.
https://www.facebook.com/Byotrol24/
Yes, good news on the new Byotrol24 next week.
Of buying.
Looking forward to watching this one grow nicely.
Record week since I started logging them for the 600ml bottle they offer.
https://www.viking-direct.co.uk/en/invirtu-hand-foam-sanitiser-600-ml-p-5145411
Bless!! You can't impress us with your half dozen argument you keep spinning year after year, why not impress us with your actions?
Tony
"have been invested in the company for a significant time (years). "
Lots of shares are up significantly because PIs sentiment and so being chased higher. The same happened during the dotcom boom.
The AGM is next week and the interims in a few weeks.
It's best to wait until the results to see if their revenues, profits, cash have grown exponentially to justify a £33m Mcap.
After all, look at the graph, the sp was significantly higher in Aug before the fy2020 results were published and fell back since.
BBs are better for everyone when the bull/bear points of the company are discussed.
Given you're been invested here for years, feel free to list the bull points. Feel free to say why, given the biggest pandemic to hit the world in 100yrs, the company only made £6m revenues, £250k adj ebitda for fy2020 and their broker only expectations are only £11.5m revenue and £1.5m adj ebitda for fy2021?
Given you've been invested for years, you will know that Byot signed a multi year, multi million pound deal with Rentokil Initial after the last spike a decade ago.
The £6m revenue for fy2020 was with multi country, multi million pound deals, which they signed after the last spike following Swine Flu a decade ago..
eg. Rentokil Initial..
MULTI Country, Multi Million Pound deal - What happened???
What happened?
The deal promises to be a multi-million pound contract for the anti-microbial products developer
https://www.cleanroomtechnology.com/news/article_page/Byotrol_agrees_multi-country_product_deal_with_Rentokil/62707